Clinical trials
Epstein-Barr Virus Infections trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 2 |
| 2015 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 2 |
| Completed | 2 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 1 |
| Cullinan Therapeutics Inc. | 1 |
| NRG Oncology | 1 |
| National University Hospital, Singapore | 1 |
| SymBio Pharmaceuticals | 1 |
| Tessa Therapeutics | 1 |
| Viracta Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epstein-Barr Virus Infections | 7 |
| Nasopharyngeal Carcinoma | 4 |
| Nasopharyngeal Neoplasms | 4 |
| Head and Neck Neoplasms | 2 |
| Recurrence | 2 |
| Immunoblastic Lymphadenopathy | 1 |
| Leukemia-Lymphoma, Adult T-Cell | 1 |
| Lymphoma | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.